Onyx-ONE Clear

Objective

The purpose of this study is to evaluate the clinical safety and effectiveness of the Resolute Onyx stent in subjects deemed at high risk for bleeding and/or medically unsuitable for more than one-month DAPT treatment receiving reduced duration (one month) of DAPT following stent implantation.

View this clinical trail on ClinicalTrials.gov.

Location:

Essentia Health East

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 12/06/2018

Research Study Categories

• Adult Studies

Specialty

• Cardiology

Contact

Cardiology Clinical Trials at 866-839-4128
or clinicaltrials@essentiahealth.org